Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.

Published

Journal Article

The clinical course of chronic lung allograft dysfunction (CLAD) is heterogeneous. Forced vital capacity (FVC) loss at onset, which may suggest a restrictive phenotype, was associated with worse survival for bilateral lung transplant recipients in one previously published single-center study.We sought to replicate the significance of FVC loss in an independent, retrospectively identified cohort of bilateral lung transplant recipients and to investigate extended application of this approach to single lung recipients.FVC loss and other potential predictors of survival after the onset of CLAD were assessed using Kaplan-Meier and Cox proportional hazards models.FVC loss at the onset of CLAD was associated with higher mortality in an independent cohort of bilateral lung transplant recipients (hazard ratio [HR], 2.75; 95% confidence interval [CI], 2.02-3.73; P < 0.0001) and in a multicenter cohort of single lung recipients (HR, 1.80; 95% CI, 1.09-2.98; P = 0.02). Including all subjects, the deleterious impact of FVC loss on survival persisted after adjustment for other relevant clinical variables (HR, 2.36; 95% CI, 1.77-3.15; P < 0.0001). In patients who develop CLAD without FVC loss, chest computed tomography features suggestive of pleural or parenchymal fibrosis also predicted worse survival in both bilateral (HR, 2.01; 95% CI, 1.16-5.20; P = 0.02) and single recipients (HR, 2.47; 95% CI, 1.24-10.57; P = 0.02).We independently validated the prognostic significance of FVC loss for bilateral lung recipients and demonstrated that this approach to CLAD classification also confers prognostic information for single lung transplant recipients. Improved understanding of these discrete phenotypes is critical to the development of effective therapies.

Full Text

Duke Authors

Cited Authors

  • DerHovanessian, A; Todd, JL; Zhang, A; Li, N; Mayalall, A; Finlen Copeland, CA; Shino, M; Pavlisko, EN; Wallace, WD; Gregson, A; Ross, DJ; Saggar, R; Lynch, JP; Belperio, J; Snyder, LD; Palmer, SM; Weigt, SS

Published Date

  • May 2016

Published In

Volume / Issue

  • 13 / 5

Start / End Page

  • 627 - 635

PubMed ID

  • 27144793

Pubmed Central ID

  • 27144793

Electronic International Standard Serial Number (EISSN)

  • 2325-6621

International Standard Serial Number (ISSN)

  • 2329-6933

Digital Object Identifier (DOI)

  • 10.1513/AnnalsATS.201510-719OC

Language

  • eng